☆ 4.6 Article

Beta-Lactam Probability of Target Attainment Success: Cefepime as a Case Study

ANTIBIOTICS-BASEL (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Infectious Diseases

Continuous Infusion of High Doses of Cefepime in Intensive Care Unit: Assessment of Steady-State Plasma Level and Incidence on Neurotoxicity

Vanessa Jean-Michel et al.

Summary: This study aimed to determine factors associated with cefepime overdosing and the incidence of cefepime-induced neurotoxicity (CIN) in critically ill patients. The results showed that 80% of patients experienced overdosing and 30% experienced neurotoxicity. Renal failure and a daily dose > 5 g were associated with overdosing, while chronic renal failure and a cefepime plasma concentration >= 60 mg/L were associated with neurotoxicity.

ANTIBIOTICS-BASEL (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

Augmented Renal Clearance in the Hematology and Oncology Populations: A Scoping Review for Pharmacists

Nicholas R. Nelson et al.

Summary: This article reviewed the literature on ARC in cancer patients and identified areas of further research to better inform pharmacy practitioners.

JOURNAL OF PHARMACY PRACTICE (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno-venous haemofiltration

Daniel J. Selig et al.

Summary: This study evaluated the pharmacokinetic parameters of meropenem in critically ill patients and found that creatinine clearance and total burn surface area significantly affect clearance and volume of distribution. Non-burn patients on continuous veno-venous hemofiltration (CVVH) had lower clearance rates compared to burn patients, indicating a need for dose adjustments. Burn surface area and CVVH did not impact the probability of target attainment.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

添加到收藏夹

Article Critical Care Medicine

An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy

Addison M. Sember et al.

Summary: This study determines the optimal extended-infusion dosing regimens for cefepime and ceftazidime in critically ill patients receiving continuous renal replacement therapy. The results suggest that a loading dose of 2 g followed by extended-infusion of 2 g every 8 hours may be the optimal choice, especially in standard effluent rates.

JOURNAL OF CRITICAL CARE (2022)

添加到收藏夹

Review Medicine, General & Internal

Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation

Dana Bakdach et al.

Summary: This review discusses and summarizes the available literature on the pharmacokinetic/pharmacodynamic (PK/PD) indices of novel beta-lactam antibiotics (NBLA) among critically ill patients with special circumstances. The evidence is limited by small sample sizes and high heterogeneity. Obesity and/or extracorporeal membrane oxygenation (ECMO) have minimal effects on the PK/PD target attainments of NBLA, while renal functionality (augmented renal clearance or renal replacement therapies) has a more substantial impact.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Microbiology

Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia

Shampa Das et al.

Summary: The study revealed that cefepime and enmetazobactam had similar concentration-time profiles in plasma and epithelial lining fluid, with a partitioning of 60.59% and 53.03% between plasma and ELF, respectively. The findings suggest that the cefepime-enmetazobactam regimen may be a promising treatment option for nosocomial pneumonia caused by multidrug-resistant Enterobacteriaceae.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Population Pharmacokinetic Modeling and Simulations of Imipenem in Burn Patients With and Without Continuous Venovenous Hemofiltration in the Military Health System

Elaine D. Por et al.

Summary: Continuous venovenous hemofiltration (CVVH) is a life-sustaining procedure for patients with severe burns and acute kidney injury. This study aimed to compare imipenem clearance in burn patients with and without CVVH, and predicted imipenem central volume and clearance across different populations using a two-compartment model. The results showed that there was no significant difference in imipenem clearance between burn patients with and without CVVH.

JOURNAL OF CLINICAL PHARMACOLOGY (2021)

添加到收藏夹

Article Infectious Diseases

Size Matters: The Influence of Patient Size on Antibiotics Exposure Profiles in Critically Ill Patients on Continuous Renal Replacement Therapy

Soo-Min Jang et al.

Summary: The study found that patients in lower weight quartiles tended to achieve higher antibiotic pharmacodynamic target attainment compared to heavier patients.

ANTIBIOTICS-BASEL (2021)

添加到收藏夹

Article Infectious Diseases

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy

Jose C. Alvarez et al.

Summary: This study found that continuous infusions of cefepime could effectively achieve PK/PD targets in patients with hematological neoplasms and post-chemotherapy febrile neutropenia.

ANTIBIOTICS-BASEL (2021)

添加到收藏夹

Article Infectious Diseases

Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelines

Cindy Lau et al.

Summary: This study found that cefepime exposure is highly predictive of CIN, with a C-min of 49 mg/L identified as the most appropriate toxicity threshold. Evaluation showed that only 29% of patients achieved therapeutic targets with cefepime dosing regimens, with impaired renal function patients more likely to have subtherapeutic concentrations and patients with normal renal function at risk of potentially toxic exposure.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)

添加到收藏夹

Review Microbiology

Optimizing Antimicrobial Drug Dosing in Critically Ill Patients

Pedro Povoa et al.

Summary: Choosing and managing antimicrobial dosing in critically ill patients is a significant challenge. The unstable pharmacokinetic status and rapidly changing clinical condition of these patients require consideration of multiple factors to maximize treatment effectiveness.

MICROORGANISMS (2021)

添加到收藏夹

Review Critical Care Medicine

Timing of antibiotic therapy in the ICU

Marin H. Kollef et al.

Summary: The timing of antibiotic administration is critical for survival in critically ill patients with severe infections, such as sepsis and septic shock. Delayed administration can lead to higher mortality rates, while the selection of appropriate antibiotics is also crucial for increasing survival.

CRITICAL CARE (2021)

添加到收藏夹

Article Critical Care Medicine

Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from the randomized phase 3 ASPECT-NP trial

Andrew F. Shorr et al.

Summary: The study evaluated the efficacy of ceftolozane/tazobactam and meropenem for the treatment of hospital-acquired bacterial pneumonia in adults, showing comparable outcomes in patients with augmented renal clearance or normal renal function. This confirms the appropriateness of ceftolozane/tazobactam every 8 hours for patients with HABP/VABP and ARC.

CRITICAL CARE (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Monte Carlo Simulation Methodologies for β-Lactam/β-Lactamase Inhibitor Combinations: Effect on Probability of Target Attainment Assessments

James M. Kidd et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2020)

添加到收藏夹

Article Infectious Diseases

Use of Monte Carlo simulation to optimize antibiotic selection for bloodstream infections caused by Enterobacteriaceae in Shandong Province, China

Cuicui Wang et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)

添加到收藏夹

Article Infectious Diseases

What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling

Isabelle K. Delattre et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

添加到收藏夹

Article Critical Care Medicine

The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcome

Christina Scharf et al.

JOURNAL OF INTENSIVE CARE (2020)

添加到收藏夹

Article Infectious Diseases

β-lactam dosing strategies: Think before you push

Jiajun Liu et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

添加到收藏夹

Article Infectious Diseases

Simulating moxalactam dosage for extended-spectrum β-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data

Chen Huang et al.

INFECTION AND DRUG RESISTANCE (2019)

添加到收藏夹

Article Critical Care Medicine

Antibiotic Exposure Profiles in Trials Comparing Intensity of Continuous Renal Replacement Therapy

Soo Min Jang et al.

CRITICAL CARE MEDICINE (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Model-Informed Drug Development: Current US Regulatory Practice and Future Considerations

Yaning Wang et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

The Role of Cefepime in the Treatment of Extended-Spectrum Beta-Lactamase Infections

Hansita B. Patel et al.

JOURNAL OF PHARMACY PRACTICE (2019)

添加到收藏夹

Review Critical Care Medicine

Optimization of the treatment with beta-lactam antibiotics in critically ill patientsguidelines from the French Society of Pharmacology and Therapeutics (Societe Francaise de Pharmacologie et TherapeutiqueSFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Societe Francaise d'Anesthesie et ReanimationSFAR)

Romain Guilhaumou et al.

CRITICAL CARE (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Full covariate modelling approach in population pharmacokinetics: understanding the underlying hypothesis tests and implications of multiplicity

Xu Steven Xu et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy

Soo Min Jang et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2018)

添加到收藏夹

Review Infectious Diseases

Pharmacokinetic/Pharmacodynamic Considerations of Beta-Lactam Antibiotics in Adult Critically Ill Patients

Anne M. Masich et al.

CURRENT INFECTIOUS DISEASE REPORTS (2018)

添加到收藏夹

Article Critical Care Medicine

Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study

Weerachai Chaijamorn et al.

JOURNAL OF INTENSIVE CARE (2018)

添加到收藏夹

Article Infectious Diseases

Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens

Nathaniel J. Rhodes et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)

添加到收藏夹

Article Urology & Nephrology

Antibiotic Dosing in Continuous Renal Replacement Therapy

Alexander R. Shaw et al.

ADVANCES IN CHRONIC KIDNEY DISEASE (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Effects of i.v. push administration on β-lactam pharmacodynamics

Jill M. Butterfield-Cowper et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing

Nikolas J. Onufrak et al.

CLINICAL THERAPEUTICS (2016)

添加到收藏夹

Article Infectious Diseases

Application of Pharmacodynamic Profiling for the Selection of Optimal β-lactam Regimens in a Large University Hospital

Pornpan Koomanachai et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)

添加到收藏夹

Article Respiratory System

Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients

R. Zachary Thompson et al.

JOURNAL OF CYSTIC FIBROSIS (2016)

添加到收藏夹

Article Medical Laboratory Technology

Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin

Keita Hirai et al.

THERAPEUTIC DRUG MONITORING (2016)

添加到收藏夹

Article Immunology

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

Jason A. Roberts et al.

CLINICAL INFECTIOUS DISEASES (2014)

添加到收藏夹

Article Pharmacology & Pharmacy

Fundamentals of Population Pharmacokinetic Modelling

Catherine M. T. Sherwin et al.

CLINICAL PHARMACOKINETICS (2012)

添加到收藏夹

Article Infectious Diseases

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

JW Mouton et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.